Regulation of self-tolerance by Qa-1-restricted CD8+ regulatory T cells

Seminars in Immunology

Volumn 23, Issue 6, 2011, Pages 446-452

  Kim, Hye Jung ^a   Cantor, Harvey ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; CD8+ regulatory T cells; HLA E; IL 15; Qa 1

Indexed keywords

CD8 ANTIGEN; HLA B ANTIGEN; HLA E ANTIGEN; NATURAL KILLER CELL RECEPTOR; QA 1 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC MEMORY; SELF TOLERANCE;

EID: 82755189880     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2011.06.001     Document Type: Review

References (89)

1. Eardley D.D., Hugenberger J., McVay-Boudreau L., Shen F.W., Gershon R.K., Cantor H. Immunoregulatory circuits among T-cell sets. I. T-helper cells induce T-cell sets to exert feedback inhibition. J Exp Med 1978, 147:1106-1115.
2. Cantor H. Reviving suppression?. Nat Immunol 2004, 5:347-349.
3. Wolf P.R., Cook R.G. The TLregion gene 37 encodes a Qa-1 antigen. J Exp Med 1990, 172:1795-1804.
4. Aldrich C.J., Waltrip R., Hermel E., Attaya M., Lindahl K.F., Monaco J.J., et al. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter. J Immunol 1992, 149:3773-3777.
5. Miller J.D., Weber D.A., Ibegbu C., Pohl J., Altman J.D., Jensen P.E. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. J Immunol 2003, 171:1369-1375.
6. b peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J Exp Med 2000, 192:613-623.
7. Kambayashi T., Kraft-Leavy J.R., Dauner J.G., Sullivan B.A., Laur O., Jensen P.E. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes. J Immunol 2004, 172:1661-1669.
8. Aldrich C.J., DeCloux A., Woods A.S., Cotter R.J., Soloski M.J., Forman J. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 1994, 79:649-658.
9. Bai A., Broen J., Forman J. The pathway for processing leader-derived peptides that regulate the maturation and expression of Qa-1b. Immunity 1998, 9:413-421.
10. Lemberg M.K., Bland F.A., Weihofen A., Braud V.M., Martoglio B. Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes. J Immunol 2001, 167:6441-6446.
11. Davies A., Kalb S., Liang B., Aldrich C.J., Lemonnier F.A., Jiang H., et al. A peptide from heat shock protein 60 is the dominant peptide bound to Qa-1 in the absence of the MHC class Ia leader sequence peptide Qdm. J Immunol 2003, 170:5027-5033.
12. Braud V., Jones E.Y., McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 1997, 27:1164-1169.
13. Stevens J., Joly E., Trowsdale J., Butcher G.W. Peptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approach. BMC Immunol 2001, 2:5.
14. Jiang H., Ware R., Stall A., Flaherty L., Chess L., Pernis B. Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing Vβ8 TCR: role of the Qa-1 molecule. Immunity 1995, 2:185-194.
15. Jiang H., Kashleva H., Xu L.X., Forman J., Flaherty L., Pernis B., et al. T cell vaccination induces TCR Vβ specific, Qa-1 restricted regulatory CD8+ T cells. Proc Natl Acad Sci USA 1998, 95:4533-4537.
16. Tang X., Maricic I., Purohit N., Bakamjian B., Reed-Loisel L.M., Beeston T., et al. Regulation of immunity by a novel population of Qa-1-restricted CD8alphaalpha+TCRalphabeta+ T cells. J Immunol 2006, 177:7645-7655.
17. Lo W.F., Woods A.S., DeCloux A., Cotter R.J., Metcalf E.S., Soloski M.J. Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nat Med 2000, 6:215-218.
18. Chen W., Zhang L., Liang B., Saenger Y., Li J., Chess L., et al. Perceiving the avidity of T cell activation can be translated into peripheral T cell regulation. Proc Natl Acad Sci USA 2007, 104:20472-20477.
19. Jiang H., Chess L. How the immune system achieves self-nonself discrimination during adaptive immunity. Adv Immunol 2009, 102:95-133.
20. Connolly D.J., Cotterill L.A., Hederer R.A., Thorpe C.J., Travers P.J., McVey J.H., et al. A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site. J Immunol 1993, 151:6089-6098.
21. Oliveira C.C., van Veelen P.A., Querido B., de Ru A., Sluijter M., Laban S., et al. The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. J Exp Med 2010, 207:207-221.
22. Jensen P.E., Sullivan B.A., Reed-Loisel L.M., Weber D.A. Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity. Immunol Res 2004, 29:81-92.
23. Rodgers J.R, Cook R.G. MHC class Ib molecules bridge innate and acquired immunity. Nat Rev Immunol 2005, 5:459-471.
24. Grimsley C., Kawasaki A., Gassner C., Sageshima N., Nose Y., Hatake K., et al. Definitive high resolution typing of HLA-E allelic polymorphisms: Identifying potential errors in existing allele data. Tissue Antigens 2002, 60:206-212.
25. Lee N., Goodlett D.R., Ishitani A., Marquardt H., Geraghty D.E. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 1998, 160:4951-4960.
26. O'Callaghan C.A., Tormo J., Willcox B.E., Braud V.M., Jakobsen B.K., Stuart D.I., et al. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol Cell 1998, 1:531-541.
27. Pietra G., Romagnani C., Mazzarino P., Falco M., Millo E., Moretta A., et al. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci USA 2003, 100:10896-10901.
28. Ulbrecht M., Modrow S., Srivastava R., Peterson P.A., Weiss E.H. Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation. J Immunol 1998, 160:4375-4385.
29. Heinzel A.S., Grotzke J.E., Lines R.A., Lewinsohn D.A., McNabb A.L., Streblow D.N., et al. HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. J Exp Med 2002, 196:1473-1481.
30. Wooden S.L., Kalb S.R., Cotter R.J., Soloski M.J. Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis. J Immunol 2005, 175:1383-1387.
31. Li J., Goldstein I., Glickman-Nir E., Jiang H., Chess L. Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E. J Immunol 2001, 167:3800-3808.
32. Lu L., Ikizawa K., Hu D., Werneck M.B.F., Wucherpfennig K.W., Cantor H. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A pathway. Immunity 2007, 26:593-604.
33. Cantor H., Boyse E.A. Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med 1975, 141:1376-1389.
34. Cantor H., Shen F.W., Boyse E.A. Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J Exp Med 1976, 143:1391-1440.
35. Noble A., Zhao Z.S., Cantor H. Suppression of immune responses by CD8 cells: II. Qa-1 on activated B-cells stimulates CD8 cell suppression of T helper 2 responses. J Immunol 1998, 160:566-571.
36. Koh D.R., Fung-Leung W.P., Ho A., Gray D., Acha-Orbea H., Mak T.W. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 1992, 256:1210-1213.
37. Gaur A., Haspel R., Mayer J.P., Fathman C.G. Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness. Science 1993, 259:91-94.
38. Jiang H., Zhang S.L., Pernis B. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 1992, 256:1213-1215.
39. Jiang H., Curran S., Ruiz-Vazquez E., Liang B., Winchester R., Chess L. Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2003, 100:8378-8383.
40. Panoutsakopoulou V., Huster K.M., McCarty N., Feinberg E., Wang R., Wucherpfennig K.W., et al. Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes. J Clin Invest 2004, 113:1218-1224.
41. Hu D., Ikizawa K., Lu L., Sanchirico M.E., Shinohara M.L., Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 2004, 5:516-523.
42. Jiang H., Canfield S.M., Gallagher M.P., Jiang H.H., Jiang Y., Zheng Z., et al. HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes. J Clin Invest 2010, 120:3641-3650.
43. Correale J., Villa A. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J Neuroimmunol 2008, 195:121-134.
44. Mazzarino P., Pietra G., Vacca P., Falco M., Colau D., Coulie P., et al. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion. Eur J Immunol 2005, 35:3240-3247.
45. Lu L., Kim H.J., Werneck M.B., Cantor H. Regulation of CD8+ regulatory T cells: interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease. Proc Natl Acad Sci USA 2008, 105:19420-19425.
46. + Treg is essential for self tolerance. Nature 2010, 467:328-332.
47. Kim H.J., Wang X., Radfar S., Sproule T.J., Roopenian D.C., Cantor H. CD8+ T regulatory cells express the Ly49 class I MHC receptor and are defective in autoimmune-prone B6-Yaa mice. Proc Natl Acad Sci USA 2011, 108:2010-2015.
48. Raulet D.H., Vance R.E., McMahon C.W. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001, 19:291-330.
49. Anfossi N., Robbins S.H., Ugolini S., Georgel P., Hoebe K., Bouneaud C., et al. Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. J Immunol 2004, 173:3773-3782.
50. Coles M.C., McMahon C.W., Takizawa H., Raulet D.H. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur J Immunol 2000, 30:236-244.
51. Ugolini S., Arpin C., Anfossi N., Walzer T., Cambiaggi A., Forster R., et al. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells. Nat Immunol 2001, 2:430-435.
52. Young N.T., Uhrberg M., Phillips J.H., Lanier L.L., Parham P. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J Immunol 2001, 166:3933-3941.
53. Roger J., Chalifour A., Lemieux S., Duplay P. Cutting edge: Ly49A inhibits TCR/CD3-induced apoptosis and IL-2 secretion. J Immunol 2001, 167:6-10.
54. Chwae Y.J., Chang M.J., Park S.M., Yoon H., Park H.J., Kim S.J., et al. Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells. J Immunol 2002, 169:3726-3735.
55. Mingari M.C., Ponte M., Cantoni C., Vitale C., Schiavetti F., Bertone S., et al. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells. Int Immunol 1997, 9:485-491.
56. Anfossi N., Pascal V., Vivier E., Ugolini S. Biology of T memory type 1 cells. Immunol Rev 2001, 181:269-278.
57. Moretta L., Romagnani C., Pietra G., Moretta A., Mingari M.C. NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol 2003, 24:136-143.
58. Pietra G., Romagnani C., Manzini C., Moretta L., Mingari M.C. The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors. J Biomed Biotechnol 2010, 907092.
59. Correia M.P., Costa A.V., Uhrberg M., Cardoso E.M., Arosa F.A. IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion. Immunobiology 2011, 216:604-612.
60. Pietra G., Romagnani C., Falco M., Vitale M., Castriconi R., Pende D., et al. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition. Eur J Immunol 2001, 31:3687-3693.
61. Romagnani C., Pietra G., Falco M., Millo E., Mazzarino P., Biassoni R., et al. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc Natl Acad Sci USA 2002, 99:11328-11333.
62. Suzuki H., Kundig T.M., Furlonger C., Wakeham A., Timms E., Matsuyama T., et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995, 268:1472-1476.
63. Burchill M.A., Yang J., Vogtenhuber C., Blazar B.R., Farrar M.A. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol 2007, 178:280-290.
64. Soper D.M., Kasprowicz D.J., Ziegler S.F. IL-2Rbeta links IL-2R signaling with Foxp3 expression. Eur J Immunol 2007, 37:1817-1826.
65. Rifa'i M., Kawamoto Y., Nakashima I., Suzuki H. Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 2004, 200:1123-1134.
66. Wang L.X., Li Y., Yang G., Pang P.Y., Haley D., Walker E.B., et al. CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice. Eur J Immunol 2010, 40:1375-1385.
67. Endharti A.T., Rifa'i M., Shi Z., Fukuoka Y., Nakahara Y., Kawamoto Y., et al. Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 2005, 175:7093-7097.
68. Saitoh O., Abiru N., Nakahara M., Nagayama Y. CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model. Endocrin 2007, 148:6040-6046.
69. Rifa'i M., Shi Z., Zhang S.Y., Lee Y.H., Shiku H., Isobe K., et al. CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells. Int Immunol 2008, 20:937-947.
70. Shi Z., Okuno Y., Rifa'i M., Endharti A.T., Akane K., Isobe K., et al. Human CD8+CXCR3+ T cells have the same function as murine CD8+CD122+ Treg. Eur J Immunol 2009, 39:2106-2119.
71. Han B., Serra P., Yamanouchi J., Amrani A., Elliott J.F., Dickie P., et al. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J Clin Invest 2005, 115:1879-1887.
72. Tsai S., Shameli A., Yamanouchi J., Clemente-Casares X., Wang J., Serra P., et al. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 2010, 32:568-580.
73. Khadra A., Tsai S., Santamaria P., Edelstein-Keshet L. On how monospecific memory-like autoregulatory CD8+ T cells can blunt diabetogenic autoimmunity: a computational approach. J Immunol 2010, 185:5962-5972.
74. Ziegler S.F. FOXP3: of mice and men. Annu Rev Immunol 2006, 24:209-226.
75. Izcue A., Coombes J.L., Powrie F. Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 2009, 27:313-338.
76. Huehn J., Siegmund K., Lehmann J.C., Siewert C., Haubold U., Feuerer M., et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med 2004, 199:303-313.
77. Maynard C.L, Harrington L.E., Janowski K.M., Oliver J.R., Zindl C.L., Rudensky A.Y., et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3-precursor cells in the absence of interleukin 10. Nat Immunol 2007, 8:931-941.
78. Sather B.D., Treuting P., Perdue N., Miazgowicz M., Fontenot J.D., Rudensky A.Y., et al. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 2007, 204:1335-1347.
79. Barnes M.J., Powrie F. Hybrid Treg cells: steel frames and plastic exteriors. Nat Immunol 2009, 10:563-564.
80. Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., Campbell D.J. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009, 10:595-602.
81. Zheng Y., Josefowicz S., Chaudhry A., Peng X.P., Forbush K., Rudensky A.Y. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010, 463:808-812.
82. Jiang H., Braunstein N.S., Yu B., Winchester R., Chess L. CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice. Proc Natl Acad Sci USA 2001, 98:6301-6306.
83. Urdahl K.B., Sun J.C., Bevan M.J. Positive selection of MHC class Ib-restricted CD8(+) T cells on hematopoietic cells. Nat Immunol 2002, 3:772-779.
84. Bendelac A., Killeen N., Littman D.R., Schwartz R.H. A subset of CD4+ thymocytes selected by MHC class I molecules. Science 1994, 263:1774-1778.
85. Bendelac A. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J Exp Med 1995, 182:2091-2096.
86. Broussard C., Fleischacker C., Horai R., Chetana M., Venegas A.M., Sharp L.L., et al. Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk. Immunity 2006, 25:93-104.
87. Atherly L.O., Lucas J.A., Felices M., Yin C.C., Reiner S.L., Berg L.J. The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells. Immunity 2006, 25:79-91.
88. Prince A.L., Yin C.C., Enos M.E., Felices M., Berg L.J. The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development. Immunol Rev 2009, 228:115-131.
89. Sullivan B.A., Kraj P., Weber D.A., Ignatowicz L., Jensen P.E. Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin. Immunity 2002, 17:95-105.